Bioequivalence and Bioavailability Forum • Generic FDC: EMA-approach

Generic FDC: EMA-approach [Design Issues]

posted by Beholder – Russia, 2018-09-04 17:23 (1666 d 15:40 ago) – Posting: # 19238
Views: 3,148

Dear Helmut,

❝ I forgot that at last year’s BioBridges Marina Feřtek of the Czech State institute for drug control (SÚKL) gave a presentation about FDCs.

Yes, saw that the conference took place and wanted to go throght the presentations. Good occasion now. Thank you.

—
Best regards
Beholder

Complete thread:

Generic FDC drug vs two monoproduct drug or vs "originator" FDC drug? Beholder 2018-09-04 11:12 [Design Issues]
- Generic FDC: EMA-approach Helmut 2018-09-04 13:04
  - Generic FDC: EMA-approach Beholder 2018-09-04 13:27
    - Generic FDC: EMA-approach Helmut 2018-09-04 13:38
      - Generic FDC: EMA-approachBeholder 2018-09-04 15:23

Admin contact
22,557 posts in 4,724 threads, 1,607 registered users;
21 visitors (0 registered, 21 guests [including 7 identified bots]).
Forum time: 09:04 CEST (Europe/Vienna)

The function of genius is not to give new answers, but to pose
new questions which time and mediocrity can resolve. H.R. Trevor-Roper

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz